# ClinicalTrials.gov record NCT06373731

> PeptideScanner retained ClinicalTrials.gov record NCT06373731 at 2026-07-30T16:19:36.914Z. Its registry update date was 2026-05-20, and PeptideScanner's reviewed identity mapping was elamipretide.

- Evidence object: `story:clinicaltrials-gov-nct06373731-elamipretide:v1`
- Evidence domain: Clinical trials
- Date in source: 2026-05-20
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct06373731-elamipretide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06373731-elamipretide-v1.json
- Content SHA-256: `7712b636e2fbcf83a8b34504ed7387fcff1321605a72f7303459ae85351426e5`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT06373731 ([`ctg-observation-nct06373731-2026-05-20-a600f5a19971`](#source-ctg-observation-nct06373731-2026-05-20-a600f5a19971))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT06373731 at 2026-07-30T16:19:36.914Z. Its registry update date was 2026-05-20, and PeptideScanner's reviewed identity mapping was elamipretide. ([`ctg-observation-nct06373731-2026-05-20-a600f5a19971`](#source-ctg-observation-nct06373731-2026-05-20-a600f5a19971))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT06373731 at 2026-07-30T16:19:36.914Z. Its registry update date was 2026-05-20, and PeptideScanner's reviewed identity mapping was elamipretide. ([`ctg-observation-nct06373731-2026-05-20-a600f5a19971`](#source-ctg-observation-nct06373731-2026-05-20-a600f5a19971))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct06373731-2026-05-20-a600f5a19971`](#source-ctg-observation-nct06373731-2026-05-20-a600f5a19971))

## Sources

<a id="source-ctg-observation-nct06373731-2026-05-20-a600f5a19971"></a>
- **ClinicalTrials.gov record NCT06373731 · retained source version 2026-05-20:a600f5a1997151245694bb91d29e9513fe32f6574aad0a628fa2bde0f6d61d73** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT06373731) (`ctg-observation-nct06373731-2026-05-20-a600f5a19971`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT06373731." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct06373731-elamipretide-v1.json SHA-256: 7712b636e2fbcf83a8b34504ed7387fcff1321605a72f7303459ae85351426e5.